MedTrace Logo

SPECT/CT Imaging of Skeletal Muscle Perfusion

NCT02791204 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2026-02-24

No results posted yet for this study

Summary

This study will use SPECT/CT imaging to assess the effect of percutaneous revascularization treatments in patients with Peripheral arterial disease and diabetes mellitus, in whom the disease can progress more quickly than in patients without diabetes.

Conditions

Interventions

DEVICE

SPECT/CT imaging following revascularization procedures

Subjects will undergo resting perfusion imaging of the feet using two separate SPECT/CT systems. Subjects will be injected with a low dose radioisotope. Heated venous blood sampling will be obtained.

DEVICE

SPECT/CT imaging

Subjects will undergo resting perfusion imaging of the feet using two separate SPECT/CT systems. Subjects will be injected with a low dose radioisotope. In addition to heated venous blood sampling, arterial blood will be continuously sampled from the radial artery for calculation of a blood input function and K1 values for foot angiosomes.

Sponsors & Collaborators

  • University of Illinois at Urbana-Champaign

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • Albert J. Sinusas, MD · Yale University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2026-01-30
Completion
2026-01-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02791204 on ClinicalTrials.gov